For the purpose of improving the prediction of cancer prognosis in the clinical researches, various algorithms have been developed to construct the predictive models with the gene signatures detected by DNA microarrays. Due to the heterogeneity of the clinical samples, the list of differentially expressed genes (DEGs) generated by the statistical methods or the machine learning algorithms often involves a number of false positive genes, which are not associated with the phenotypic differences between the compared clinical conditions, and subsequently impacts the reliability of the predictive models. In this study, we proposed a strategy, which combined the statistical algorithm with the gene-pathway bipartite networks, to generate the reliable lists of cancer-related DEGs and constructed the models by using support vector machine for predicting the prognosis of three types of cancers, namely, breast cancer, acute myeloma leukemia, and glioblastoma. Our results demonstrated that, combined with the gene-pathway bipartite networks, our proposed strategy can efficiently generate the reliable cancer-related DEG lists for constructing the predictive models. In addition, the model performance in the swap analysis was similar to that in the original analysis, indicating the robustness of the models in predicting the cancer outcomes.
Multi-family enzymes are of great importance in life, disease and other domains. However, in terms of the classification of enzymes, the information of multi-family enzymes is always removed from the dataset to account for the limitation of traditional single-label prediction methods. In order to predict multiple classes of multi-family enzymes, we adopted two multi-label learning algorithms, namely RAkEL-RF and MLKNN, and two types of protein descriptors, namely CTD and PseAAC, to generate four predictors, RAkEL-RF-CTD, RAkEL-RF-PseAAC, MLKNN-CTD and MLKNN-PseAAC. When the four predictors were tested on a training set with 10-fold cross validation, the overall success rates reached 97.99%, 96.07%, 96.01% and 95.31%, respectively. For the independent test set, the corresponding rates reached 97.57%, 95.03%, 95.9% and 93.9%, respectively. In conclusion, it proved the outstanding prediction capability and robustness of our predictors from the extremely small difference between two sets for each predictor and the relatively higher accuracy. In addition, three of seven pairs of homologous enzymes with different functions and eighteen of twenty-three distantly related enzymes with a similar family were correctly classified by the RAkEL-RF-CTD predictor. These results indicated the extensive applicability of our predictors.
This is a PDF file of an article that has undergone enhancements after acceptance, such as the addition of a cover page and metadata, and formatting for readability, but it is not yet the definitive version of record. This version will undergo additional copyediting, typesetting and review before it is published in its final form, but we are providing this version to give early visibility of the article. Please note that, during the production process, errors may be discovered which could affect the content, and all legal disclaimers that apply to the journal pertain.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.